Wordt geladen...
Impact of direct-acting antiviral therapy for hepatitis C–related hepatocellular carcinoma
With the introduction of direct-acting antiviral (DAA) agents, hepatitis C virus (HCV) treatment has dramatically improved. However, there are insufficient data on the benefits of DAA therapy in hepatocellular carcinoma (HCC). The purpose of this study was to investigate the outcome of patients who...
Bewaard in:
| Gepubliceerd in: | PLoS One |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7244104/ https://ncbi.nlm.nih.gov/pubmed/32442193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0233212 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|